Aix Marseille Univ, School of Medicine, La Timone Medical Campus, EA 3279: CEReSS - Health Service Research and Quality of life Center, Marseille, France.
Aix Marseille Univ, School of Medicine, La Timone Medical Campus, EA 3279: CEReSS - Health Service Research and Quality of life Center, Marseille, France; Department of Psychiatry, Sainte-Marguerite University Hospital, Marseille, France.
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:84-89. doi: 10.1016/j.pnpbp.2018.08.024. Epub 2018 Aug 25.
Guidelines have been edited for the treatment of schizophrenia (SZ) and bipolar disorders (BD). Background regimen is currently recommended for both illnesses (antipsychotic drug for SZ and mood stabilizer for BD). The recommendations are less clear for major depression in these disorders. Long-term anxiolytic and hypnotic prescriptions may have potential side effects and should be withdrawn as soon as possible.
The aim of this study was to investigate the prevalence and associated factors of Potentially Inappropriate Psychotropic drugs (PIP) in a large multicenter sample of Homeless Schizophrenia (SZ) and Bipolar Disorder (BD) (HSB) patients.
This multicenter study was conducted in 4 French cities: Lille, Marseille, Paris and Toulouse. PIP was defined by at least one item among: (i) absence of background regimen (antipsychotic for SZ or mood stabilizer for BD), (ii) absence of antidepressant for major depressive disorder and (iii) daily long-term anxiolytic or (iv) hypnotic prescription.
Overall, 703 HSB patients, mean aged 38 years and 82.9% men were included, 487 SZ (69.3%) and 216 BD (30.7%). 619 (88.4%) of the patients reported at least one PIP. 386 (54.9%) patients had an inappropriate background regimen prescription (209(43.4%) of SZ had no antipsychotic prescription and 177(81.9%) of BD no mood stabilizer), 336 (48%) had an inappropriate antidepressant prescription (with no significant difference between SZ and BD), 326 (46.4%) had an inappropriate prescription of anxiolytics and 107 (15.2%) had an inappropriate prescription of hypnotics. 388(55%) of the subjects were diagnosed with major depression but only 52(13%) of them were administered antidepressants. In multivariate analysis, PIP was associated with bipolar disorder diagnosis (aOR = 4.67 [1.84-11.89], p = 0.001), current major depressive disorder (aOR = 27.72 [9.53-80.69], p < 0.0001), lower rate of willingness to ask for help (aOR = 0.98[0.96-0.99], p = 0.001). Potentially inappropriate background regimen prescription was associated with bipolar disorder diagnosis (aOR = 6.35 [3.89-10.36], p < 0.0001), lower willingness to ask for help (aOR = 0.99[0.98-0.99], p = 0.01) and lack of lifetime history of psychiatric care (aOR = 0.30[0.12-0.78], p = 0.01). Inappropriate antidepressant prescription was associated with antisocial personality disorder (aOR = 1.58 [1.01-2.48], p = 0.04) and current substance use disorder (aOR = 2.18[1.48-3.20], p < 0.0001).
The present findings suggest that almost 9 on 10 HSB subjects may receive a PIP including inappropriate prescriptions or absence of appropriate prescription. Bipolar disorder and/or major depression should be targeted in priority and treated with mood stabilizers and/or antidepressants in this population, while anxiolytics and hypnotics should be withdrawn as much as possible. Major depression should be particularly explored in subjects with comorbid antisocial personality disorder and substance use disorder. The psychiatric care has been associated with better appropriate psychotropic prescriptions and should be reinforced in this population.
精神分裂症(SZ)和双相情感障碍(BD)的治疗指南已经过编辑。目前推荐对这两种疾病都采用背景治疗方案(SZ 用抗精神病药物,BD 用情绪稳定剂)。然而,对于这些疾病中的重度抑郁症,推荐意见并不明确。长期使用的抗焦虑药和催眠药可能有潜在的副作用,应尽快停药。
本研究旨在调查一个大型多中心流浪的精神分裂症(SZ)和双相情感障碍(BD)(HSB)患者样本中潜在不适当精神药物(PIP)的流行情况和相关因素。
这项多中心研究在法国 4 个城市进行:里尔、马赛、巴黎和图卢兹。PIP 通过以下至少一项来定义:(i)无背景治疗方案(SZ 的抗精神病药物或 BD 的情绪稳定剂),(ii)无抗抑郁药治疗重度抑郁症,以及(iii)长期每日使用抗焦虑药或(iv)催眠药。
共纳入 703 名 HSB 患者,平均年龄 38 岁,82.9%为男性,其中 487 名 SZ(69.3%)和 216 名 BD(30.7%)。619 名(88.4%)患者报告至少有一种 PIP。386 名(54.9%)患者存在不适当的背景治疗方案处方(209 名 SZ(43.4%)没有抗精神病药物处方,177 名 BD(81.9%)没有情绪稳定剂),336 名(48%)患者存在不适当的抗抑郁药处方(SZ 和 BD 之间无显著差异),326 名(46.4%)患者存在不适当的抗焦虑药处方,107 名(15.2%)患者存在不适当的催眠药处方。388 名(55%)患者被诊断为重度抑郁症,但只有 52 名(13%)患者接受了抗抑郁药治疗。多变量分析显示,PIP 与双相障碍诊断(比值比[aOR]:4.67 [1.84-11.89],p=0.001)、当前重度抑郁症(aOR:27.72 [9.53-80.69],p<0.0001)、求助意愿较低(aOR:0.98[0.96-0.99],p=0.001)相关。潜在不适当的背景治疗方案与双相障碍诊断(aOR:6.35 [3.89-10.36],p<0.0001)、求助意愿较低(aOR:0.99[0.98-0.99],p=0.01)和缺乏终身精神卫生保健史(aOR:0.30[0.12-0.78],p=0.01)相关。不适当的抗抑郁药处方与反社会人格障碍(aOR:1.58 [1.01-2.48],p=0.04)和当前物质使用障碍(aOR:2.18[1.48-3.20],p<0.0001)相关。
本研究结果表明,近 9 成的 HSB 患者可能会接受 PIP,包括不适当的处方或缺乏适当的处方。在该人群中,应优先针对双相障碍和/或重度抑郁症进行治疗,使用情绪稳定剂和/或抗抑郁药,同时尽可能停用抗焦虑药和催眠药。对于伴有反社会人格障碍和物质使用障碍的重度抑郁症患者应特别关注。精神卫生保健与更好的适当精神药物处方相关,应在该人群中加强。